Downregulation of HS6ST2 by miR-23b-3p enhances matrix degradation through p38 MAPK pathway in osteoarthritis

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with complex molecular underpinnings.
• HS6ST2, an enzyme involved in sulfate transfer, is downregulated in OA cartilage, but its regulatory mechanisms remain unclear.

Purpose of the Study:

• To investigate the regulatory mechanism of HS6ST2 in osteoarthritis.
• To elucidate the role of HS6ST2 in chondrocyte matrix degradation and OA pathogenesis.

Main Methods:

• Quantitative analysis of HS6ST2 and miR-23b-3p expression in OA and normal cartilage.
• In vitro studies using chondrocytes to assess the effects of miR-23b-3p and HS6ST2 manipulation on matrix metalloproteinase 13 (MMP13) levels and matrix degradation.
• Investigation of the involvement of the p38 mitogen-activated protein kinase (MAPK) pathway.

Main Results:

• HS6ST2 expression is significantly lower in OA-damaged cartilage compared to healthy cartilage from the same patients.
• miR-23b-3p, found at higher levels in OA cartilage, directly targets and downregulates HS6ST2 expression.
• Downregulation of HS6ST2 promotes MMP13 expression and matrix degradation in chondrocytes, mediated by p38 MAPK activation.

Conclusions:

• Downregulated HS6ST2, targeted by miR-23b-3p, contributes to OA pathogenesis by promoting matrix degradation through p38 MAPK activation.
• This miR-23b-3p/HS6ST2/p38 MAPK axis represents a potential therapeutic target for osteoarthritis.